Lars Hedbys

Lars Hedbys is the Chairman of the Board at Chosa Oncology and Strominnate Therapeutics AB. Additionally, Lars serves as a Board Member at Xintela AB, Asgard Therapeutics, and Cell Invent AB. Lars is also a Member of the Board at RhoVac and a Partner at Ventac Partners, a life science consulting firm. With a Ph.D. in Applied Biochemistry from Lund University and a M.Sc. in Chemical Engineering from Chalmers University of Technology, Lars Hedbys has a strong background in the life science industry and brings valuable expertise to the companies Lars is involved with.